167sek
-1,5 %
Date:2024-05-21Time:17:29:00Latest report:Q4-2023List:First NorthTicker:GABA
Market Cap:32 msekEnterprise Value:30 msekNet Sales:- msekEarnings:-9,44 msekEmployees:0ISIN:SE0010869552

Ratios

10-year key figure history for Gabather turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Gabather with index and moving average MA50 and MA200.

Stockprice:1,67
MA50:1,79
MA200:1,78
Price/MA200:-6,2 %
RSI (14):48,3
Price/MA50:-6,7 %

Description

Gabather AB is engaged in developing novel drugs to treat several diseases originating in the central nervous system. It has four main focus areas anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as cognition-enhancing treatments, including for Alzheimer's disease.

Biotechnology